| Literature DB >> 22163189 |
Narlize Silva Lira1, Ricardo Carneiro Montes1, Josean Fechine Tavares1, Marcelo Sobral da Silva1, Emidio V L da Cunha2, Petronio Filgueiras de Athayde-Filho1, Luis Cezar Rodrigues1, Celidarque da Silva Dias1, Jose Maria Barbosa-Filho1.
Abstract
Aplysina is the best representative genus of the family Aplysinidae. Halogenated substances are its main class of metabolites. These substances contribute greatly to the chemotaxonomy and characterization of the sponges belonging to this genus. Due to their pharmacological activities, these alkaloids are of special interest. The chemistry of halogenated substances and of the alkaloids has long been extensively studied in terrestrial organisms, while the number of marine organisms studied has just started to increase in the last decades. This review describes 101 halogenated substances from 14 species of Aplysina from different parts of the world. These substances can be divided into the following classes: bromotyramines (A), cavernicolins (B), hydroverongiaquinols (C), bromotyrosineketals (D), bromotyrosine lactone derivatives (E), oxazolidones (F), spiroisoxazolines (G), verongiabenzenoids (H), verongiaquinols (I), and dibromocyclohexadienes (J). A compilation of their (13)C NMR data is also part of the review. For this purpose 138 references were consulted.Entities:
Keywords: 13C NMR; Aplysina; halogenated substances; marine sponges; review
Mesh:
Substances:
Year: 2011 PMID: 22163189 PMCID: PMC3229238 DOI: 10.3390/md9112316
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Bioactivities of marine sponges of the Aplysina genus.
| Activity/Species Name | Type of Extract | Bioassays Models, Organism, Dose or Route of Administration | Result | Ref. |
|---|---|---|---|---|
| MeOH Ext. | Agar plate- | Active | [ | |
| MeOH Ext. | Agar plate- | Active | [ | |
| MeOH-Toluene | Agar plate- | Active | [ | |
| Chromatographic Fraction | Agar plate- | Active | [ | |
| MeOH Ext. | Agar plate- | Active | [ | |
| MeOH Ext. | Agar plate- | Active | [ | |
| Acetone Ext. | Agar plate- | Active | [ | |
| Ether Ext. | Agar plate- | Active | [ | |
| Ether Ext. | Agar plate- | Inactive | [ | |
| CHCl3 Ext. | Agar plate- | Active | [ | |
| CHCl3 Ext. | Agar plate- | Inactive | [ | |
| Acetone Ext. | Agar plate- | Inactive | [ | |
| ETOH (95%) Ext. | Agar plate- | Inactive | [ | |
| Benzene Ext. | Agar plate- | Inactive | [ | |
| Ether Ext. | Agar plate- | Inactive | [ | |
| Acetone Ext. | Agar plate- | Inactive | [ | |
| ETOH (95%) Ext. | Agar plate- | Inactive | [ | |
| Benzene Ext. | Agar plate- | Inactive | [ | |
| CHCl3 Ext. | Agar plate- | Inactive | [ | |
| MeOH Ext. | Agar plate- | Inactive | [ | |
| MeOH Ext. | Agar plate- | Weak | [ | |
| Activity | ||||
| MeOH Ext. | Agar plate- | Inactive | [ | |
| MeOH Ext. | Agar plate- | Inactive | [ | |
| MeOH-Toluene | Cell culture- | Active | [ | |
| CHCl3-MeOH Ext. (1:1) | Cell culture- | Active | [ | |
| MeOH Ext. | Cell culture- | Active | [ | |
| MeOH-Toluene | Cell culture- | Active | [ | |
| Chromatographic Fraction | Cell culture- | Active | [ | |
| Isopropanol Ext. | Cell culture- | Active | [ | |
| Isopropanol Ext. | Cell culture- | Active | [ | |
| Isopropanol Ext. | Cell culture- | Active | [ | |
| MeOH Ext. | Cell culture- | Inactive | [ | |
| ETOH (95%) Ext. | Mouse-Intragastric-Dose 200 mg/kg | Active | [ | |
Distribution of the halogenated substances in the genus Aplysina.
| Species | Halogenated Substances | Substance Code | Nucleus | Ref. |
|---|---|---|---|---|
| Aeroplysinine 2 | 25 | E1 | [ | |
| Aplysinadiene | 26 | E1 | [ | |
| (7 | 29 | F1 | [ | |
| ( | 31 | F1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| Isofistularin-3 | 48 | G2 | [ | |
| Aerophobin-1 | 76 | G7 | [ | |
| 2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl) acetamide | 84 | H | [ | |
| 3,5-Dibromo-4-methoxyphenol | 85 | H | [ | |
| Methyl 2-(3,5-dibromo-2-hydroxy-4-methoxyphenyl) acetate | 86 | H | [ | |
| Dibromoverongiaquinol or dienone or 3-5-dibromo-1-hydroxy-4-oxocyclohexa-2-5-diene-1-acetamide | 94 | I1 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| (7 | 29 | F1 | [ | |
| 11,19-Dideoxyfistularin 3 | 33 | G1 | [ | |
| Archerine | 43 | G1 | [ | |
| Fistularin-3 | 46 | G2 | [ | |
| 11-Ketofistularin 3 | 51 | G2 | [ | |
| Aplysina compound 1 or 1-Oxa-2-azaspiro[ | 57 | G4 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| (+) Aeroplysinin 1 | 100 | J | [ | |
| (−) Aeroplysinin 1 | 100 | J | [ | |
| 2-(3,5-Dibromo-4,4-dimethoxy-1-hydroxy-2,5-cyclohexadien-1-yl) acetamide | 21 | D1 | [ | |
| Caissarine C | 42 | G1 | [ | |
| Caissarine B | 53 | G2 | [ | |
| Agelocaissarine A1 | 58 | G4 | [ | |
| Agelocaissarine A2 | 59 | G4 | [ | |
| Agelocaissarine B1 | 60 | G4 | [ | |
| Agelocaissarine B2 | 61 | G4 | [ | |
| Caissarine A | 79 | G8 | [ | |
| 2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl)acetamide | 21 | D1 | [ | |
| (7 | 29 | F1 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| Aplysinametabolite or Methyl 4-((5 | 64 | G7 | [ | |
| Methyl 4-((5 | 65 | G7 | [ | |
| Methyl-4-((5 | 66 | G7 | [ | |
| Aplysinamisine-1 | 67 | G7 | [ | |
| Aplysinamisine-2 | 68 | G7 | [ | |
| Aplysinamisine-3 | 69 | G7 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| Cavernicolin-1 | 5 | B1 | [ | |
| 5-Bromo-7α-chlorocavernicolin | 7 | B2 | [ | |
| 5-Bromo-7β-chlorocavernicolin | 8 | B2 | [ | |
| 7β-Bromo-5-chlorocavernicolin | 9 | B2 | [ | |
| 7α-Bromo-5-chlorocavernicolin | 10 | B2 | [ | |
| Monobromocavernicolin or 5-Bromocavernicolin | 11 | B2 | [ | |
| 5-Chlorocavernicolin | 12 | B2 | [ | |
| 7-Bromocavernicolenone | 13 | B3 | [ | |
| 7-Chlorocavernicolenone | 14 | B3 | [ | |
| 2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide | 21 | D1 | [ | |
| Aeroplysinine 2 | 25 | E1 | [ | |
| 11,19-Dideoxyfistularin 3 | 33 | G1 | [ | |
| 12( | 36 | G1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Oxohomoaerothionin | 44 | G1 | [ | |
| 11-Deoxyfistularin-3 | 45 | G2 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| Isofistularin3 | 48 | G2 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| (+) 3-Bromo-5-chloroverongiaquinol or (+)-3-Bromo-5-chloro-1-hydroxy-4-oxo-2,5-cyclohexadiene-1-acetamide | 91 | I1 | [ | |
| (+) 3-Bromoverongiaquinol or (+)-3-Bromo-1-hydroxy-4-oxo-2,5-cyclohexadiene-1-acetamide | 92 | I1 | [ | |
| (DL) 5-Bromoverongiaquinol | 93 | I1 | [ | |
| Dichloroverongiaquinol | 95 | I1 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| Aeroplysinine 2 | 25 | E1 | [ | |
| Aplysamine1 | 1 | A | [ | |
| Aplysamine2 | 2 | A | [ | |
| Aplysfistularine | 4 | A | [ | |
| 5-Amino-2,6-dichloro-4-hydroxycyclohex-2-enone acetic acid lactam | 15 | B4 | [ | |
| 5-Amino-2-bromo-6-chloro-4-hydroxy-cyclohex-2-enone acetic acid lactam (5-bromo-7-chlorocavernicolin) | 16 | B4 | [ | |
| 5-Amino-2-6-dibromo-4-hydroxy-cyclohex-2-enone acetic acid lactam or Cavernicolin | 17 | B4 | [ | |
| 4,6-Dibromohomogentisamide | 18 | C | [ | |
| 3,5-Dibromohydroquinone-2-acetamide | 19 | C | [ | |
| 2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide | 21 | D1 | [ | |
| Aeroplysinine 2 | 25 | E1 | [ | |
| (7 | 29 | F1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Fistularin-3 | 46 | G2 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| Purealidin-L | 78 | G7 | [ | |
| 2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl) acetamide | 84 | H | [ | |
| 2,6-Dibromo-1,4-benzoquinone | 87 | I1 | [ | |
| 2,6-Dichloro-4-hydroxycyclohexa-2-5-dienone-4-acetamide | 89 | I1 | [ | |
| 2-Bromo-6-chloro-4-hydroxycyclohexa-2,5-dienone-4-acetamide | 90 | I1 | [ | |
| Dibromoverongiaquinol or dienone or 3-5-dibromo-1-hydroxy-4-oxocyclohexa-2-5-diene-1-acetamide | 94 | I1 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| Cavernicolin-1 | 5 | B1 | [ | |
| Cavernicolin-2 | 6 | B1 | [ | |
| 3,5-Dibromohydroquinone-2-acetamide | 19 | C | [ | |
| 2’-(3,5-Dibromo-4-hydroxyphenyl) acetamide | 20 | C | [ | |
| 2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide | 21 | D1 | [ | |
| Aeroplysinine 2 | 25 | E1 | [ | |
| (7 | 29 | F1 | [ | |
| 11-Epi-fistularin-3 | 34 | G1 | [ | |
| 11-Hydroxyfistularin-3 | 35 | G1 | [ | |
| 12( | 36 | G1 | [ | |
| 12( | 37 | G1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Fistularin-3 | 46 | G2 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| 11-Hydroxyaerothionin | 50 | G2 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| Aplysinamisine-1 | 67 | G7 | [ | |
| Araplysillin | 70 | G7 | [ | |
| Fistularin-1 | 72 | G7 | [ | |
| Fistularin-2 | 73 | G7 | [ | |
| 74 | G7 | [ | ||
| Aerophobin-1 | 76 | G7 | [ | |
| Aerophobin-2 | 77 | G7 | [ | |
| Aeroplysinin 1 | 100 | J | [ | |
| Aplysinafulvin | 101 | J | [ | |
| Aerothionin | 41 | G1 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| Aplysinone A | 54 | G3 | [ | |
| Aplysinone D | 55 | G3 | [ | |
| Aplysinone B | 56 | G4 | [ | |
| Calafianin | 62 | G5 | [ | |
| Aplysinone C | 63 | G6 | [ | |
| 2-(3,5-dibromo-2-hydroxy-4-methoxyphenyl) acetic acid | 83 | H | [ | |
| 5-((2,6-Dibromo-4-(2-oxooxazolidin-5-yl)-phenoxy)-methyl)-5-methoxyoxazolidin-2-one | 32 | F3 | [ | |
| 11,19-Dideoxyfistularin 3 | 33 | G1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Fistularin-3 | 46 | G2 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| 11-Dihydroaerothionin | 49 | G2 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| Aplysina metabolite 14 | 66 | G7 | [ | |
| 14-Oxoaerophobin-2 | 75 | G7 | [ | |
| Aerophobin-1 | 76 | G7 | [ | |
| Aerophobin-2 | 77 | G7 | [ | |
| (5 | 80 | G9 | [ | |
| 2-(3-Dibromo-4-hydroxyphenyl)- | 82 | H | [ | |
| (7 | 29 | F1 | [ | |
| (7 | 30 | F2 | [ | |
| 11,19-Dideoxyfistularin-3 | 33 | G1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Fistularin-3 | 46 | G2 | [ | |
| 11-Hydroxyaerothionin | 50 | G2 | [ | |
| 11-Oxoaerothionin | 52 | G2 | [ | |
| (1′ | 98 | I2 | [ | |
| (1′ | 99 | I2 | [ | |
| (+) Aeroplysinin 1 | 100 | J | [ | |
| Aplysamine1 | 1 | A | [ | |
| Aplysamine2 | 2 | A | [ | |
| Aplyzanzine A | 3 | A | [ | |
| 2-(3,5-Dibromo-4-ethoxy-1-hydroxy-4-methoxy-2,5-cyclohexadien-1-yl)-ethanamide | 22 | D2 | [ | |
| Aeroplysinine 2 | 25 | E1 | [ | |
| (7 | 30 | F2 | [ | |
| ( | 31 | F1 | [ | |
| 11,19-Dideoxyfistularin-3 | 33 | G1 | [ | |
| 11-Oxofistularin-3 | 38 | G1 | [ | |
| 19-Deoxy-11-oxofistularin | 39 | G1 | [ | |
| 19-Deoxyfistularin-3 | 40 | G1 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Hemifistularin-3 | 71 | G7 | [ | |
| (10 | 81 | G9 | [ | |
| 2-(3-Bromo-4-hydroxyphenyl)- | 82 | H | [ | |
| Aplysinketal A | 23 | D1 | [ | |
| Aplysinketal B | 24 | D1 | [ | |
| Aplysinolide | 27 | E2 | [ | |
| Aplysinimine | 28 | E2 | [ | |
| (7 | 30 | F2 | [ | |
| Aerothionin | 41 | G1 | [ | |
| Homoaerothionin | 47 | G2 | [ | |
| 2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl)-acetamide | 84 | H | [ | |
| 2,6-Dibromo-4-acetamide-4-hydroxycyclohexadienone | 88 | I1 | [ | |
| Aplysina hydroxydienone or Dibromo compound 10 | 96 | I1 | [ | |
| Aplysina hydroxydienoic methyl esther | 97 | I1 | [ |
Basic skeletons of the halogenated substances isolated from sponges of the Aplysina.
Substituent groups of the halogenated substances.
Halogenated substances found in the genus Aplysina.
| Halogen Compound | R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 | R9 | Nucleus |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Me | Me | - | - | - | - | - | - | - | A |
| 2 | H | (E) BrMeOPhCH2CNOHCO- | - | - | - | - | - | - | - | A |
| 3 | H | Br2MeOPhCH2CHN(CH3)2CO- | - | - | - | - | - | - | - | A |
| 4 | Me | Me | Me | - | - | - | - | - | - | A |
| 5 | Br | H | Br | - | - | - | - | - | - | B1 |
| 6 | H | Br | Br | - | - | - | - | - | - | B1 |
| 7 | Cl | H | Br | - | - | - | - | - | - | B2 |
| 8 | H | Cl | Br | - | - | - | - | - | - | B2 |
| 9 | Br | H | Cl | - | - | - | - | - | - | B2 |
| 10 | H | Br | Cl | - | - | - | - | - | - | B2 |
| 11 | H | H | Br | - | - | - | - | - | - | B2 |
| 12 | H | H | Cl | - | - | - | - | - | - | B2 |
| 13 | Br | - | - | - | - | - | - | - | - | B3 |
| 14 | Cl | - | - | - | - | - | - | - | - | B3 |
| 15 | H | Cl | Cl | - | - | - | - | - | - | B4 |
| 16 | H | Cl | Br | - | - | - | - | - | - | B4 |
| 17 | H | Br | Br | - | - | - | - | - | - | B4 |
| 18 | OH | H | Br | OH | Br | - | - | - | - | C |
| 19 | Br | OH | Br | H | OH | - | - | - | - | C |
| 20 | H | Br | OH | Br | H | - | - | - | - | C |
| 21 | Me | Me | - | - | - | - | - | - | - | D1 |
| 22 | Et | Me | - | - | - | - | - | - | - | D2 |
| 23 | Me | Butyl | - | - | - | - | - | - | - | D1 |
| 24 | Me | Pentyl | - | - | - | - | - | - | - | D1 |
| 25 | MeO | OH | H | - | - | - | - | - | - | E1 |
| 26 | H | Br | (E) CH2=CH=CH=CH- | OH | Br | - | - | - | - | E1 |
| 27 | Br | OMe | Br | H | - | - | - | - | E2 | |
| 28 | Br | OMe | H | Br | H | - | - | - | - | E2 |
| 29 | -CH2( | - | - | - | - | - | - | - | - | F1 |
| 30 | -CH2( | - | - | - | - | - | - | - | - | F2 |
| 31 | -CH2( | - | - | - | - | - | - | - | - | F1 |
| 32 | -CH2MeOoxz | - | - | - | - | - | - | - | - | F3 |
| 33 | -(CH2)3OBr2Ph(CH2)2- | - | - | - | - | - | - | - | - | G1 |
| 34 | -CH2( | - | - | - | - | - | - | - | - | G1 |
| 35 | -(CH2)3OBr2Ph( | - | - | - | - | - | - | - | - | G1 |
| 36 | - | - | - | - | - | - | - | - | G1 | |
| 37 | - | - | - | - | - | - | - | - | G1 | |
| 38 | - | - | - | - | - | - | - | - | G1 | |
| 39 | - | - | - | - | - | - | - | - | G1 | |
| 40 | -CH2CHOHCH2OBr2Ph(CH2)2- | - | - | - | - | - | - | - | - | G1 |
| 41 | -(CH2)4- | - | - | - | - | - | - | - | - | G1 |
| 42 | -CH2CHOH(CH2)3- | - | - | - | - | - | - | - | - | G1 |
| 43 | -(CH2)2CH(imz)2(CH2)3- | - | - | - | - | - | - | - | - | G1 |
| 44 | - | - | - | - | - | - | - | - | G1 | |
| 45 | -(CH2)3OBr2PhCHOHCH2- | - | - | - | - | - | - | - | - | G2 |
| 46 | -CH2( | - | - | - | - | - | - | - | - | G2 |
| 47 | -(CH2)5- | - | - | - | - | - | - | - | - | G2 |
| 48 | -CH2CHOHCH2OBr2PhCHOHCH2- | - | - | - | - | - | - | - | - | G2 |
| 49 | -CH2(CHOH)2CH2- | - | - | - | - | - | - | - | - | G2 |
| 50 | -CH2CHOH(CH)2- | - | - | - | - | - | - | - | - | G2 |
| 51 | - | - | - | - | - | - | - | - | G2 | |
| 52 | -CH2CH2O(CH2)2- | - | - | - | - | - | - | - | - | G2 |
| 53 | -(CH2)5COHCH2- | - | - | - | - | - | - | - | - | G2 |
| 54 | -(CH2)5- | - | - | - | - | - | - | - | - | G3 |
| 55 | -(CH2)4- | - | - | - | - | - | - | - | - | G3 |
| 56 | -(CH2)5- | H | Br | OH | H | Br | H | H | OH | G4 |
| 57 | -CH2CH2O(CH2)2- | Br | H | H | OH | H | Br | OH | H | G4 |
| 58 | -CH2CHOH(CH)2- | H | Br | OH | H | Br | H | H | OH | G4 |
| 59 | -CH2CHOH(CH)2- | Br | H | OH | H | H | Br | H | OH | G4 |
| 60 | -CH2CHOH(CH2)3- | H | Br | OH | H | Br | H | H | OH | G4 |
| 61 | -CH2CHOH(CH2)3- | Br | H | OH | H | H | Br | H | OH | G4 |
| 62 | -(CH2)4- | - | - | - | - | - | - | - | - | G5 |
| 63 | -(CH2)5- | - | - | - | - | - | - | - | - | G6 |
| 64 | - | - | - | - | - | - | - | - | G7 | |
| 65 | - | - | - | - | - | - | - | - | G7 | |
| 66 | - | - | - | - | - | - | - | - | G7 | |
| 67 | -CH2(Z)(CH)2imzNH2 | - | - | - | - | - | - | - | - | G7 |
| 68 | -(CH2)5gnd | - | - | - | - | - | - | - | - | G7 |
| 69 | -(CH2)3OBr2PhCHOHCH2NHAc | - | - | - | - | - | - | - | - | G7 |
| 70 | -(CH2)3OBr2Ph(CH2)2NHSO3Na | - | - | - | - | - | - | - | - | G7 |
| 71 | -CH2CHOHBr2PhOH | - | - | - | - | - | - | - | - | G7 |
| 72 | -(CH2)3OBr2Phoxz | - | - | - | - | - | - | - | - | G7 |
| 73 | -CH2Br2PhOoxz | - | - | - | - | - | - | - | - | G7 |
| 74 | - | - | - | - | - | - | - | - | G7 | |
| 75 | -(CH2)3imzONH2 | - | - | - | - | - | - | - | - | G7 |
| 76 | -(CH2)2imz | - | - | - | - | - | - | - | - | G7 |
| 77 | -(CH2)3imzNH2 | - | - | - | - | - | - | - | - | G7 |
| 78 | -(CH2)4gnd | - | - | - | - | - | - | - | - | G7 |
| 79 | -CH2CHOH(CH2)2gnd | - | - | - | - | - | - | - | - | G8 |
| 80 | Me | - | - | - | - | - | - | - | - | G9 |
| 81 | Et | - | - | - | - | - | - | - | - | G9 |
| 82 | -(CH2)2N(Me)3 | H | - | - | - | - | - | - | - | H |
| 83 | OH | - | - | - | - | - | - | - | H | |
| 84 | OH | - | - | - | - | - | - | - | H | |
| 85 | OH | H | - | - | - | - | - | - | - | H |
| 86 | OH | - | - | - | - | - | - | - | H | |
| 87 | Br | H | H | O | Br | - | - | - | - | I1 |
| 88 | Br | H | OH | Br | - | - | - | - | I1 | |
| 89 | Cl | H | OH | Cl | - | - | - | - | I1 | |
| 90 | Br | H | OH | Cl | - | - | - | - | I1 | |
| 91 | Br | OH | OH | Cl | - | - | - | - | I1 | |
| 92 | Br | OH | OH | H | - | - | - | - | I1 | |
| 93 | H | OH | OH | Br | - | - | - | - | I1 | |
| 94 | Br | H | OH | Br | - | - | - | - | I1 | |
| 95 | Cl | H | OH | Cl | - | - | - | - | I1 | |
| 96 | Br | H | OH | Br | - | - | - | - | I1 | |
| 97 | Br | H | O | CH2CH2OCH3 | Br | - | - | - | - | I1 |
| 98 | OH | OH | - | - | - | - | - | - | - | I2 |
| 99 | OH | OH | - | - | - | - | - | - | - | I2 |
| 100 | OH | OH | CH2CN | - | - | - | - | - | - | J |
| 101 | MeO | OH | CH2CONH2 | - | - | - | - | - | - | J |
gnd = Guanidine; imz = Imidazole; oxz = Oxazolidinone.
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Bromotyramines.
| Position | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1 | 140.3 | 140.3 | 137.94 | 138.58 |
| 2 | 134.4 | 134.4 | 132.78 | 132.80 |
| 3 | 118.7 | 118.7 | 117.74 | 118.02 |
| 4 | 152.1 | 152.1 | 150.87 | 151.30 |
| 5 | 118.7 | 118.7 | 117.74 | 118.02 |
| 6 | 134.4 | 134.4 | 132.78 | 132.80 |
| 7 | 35.2 | 35.2 | 34.20 | 32.26 |
| 8 | 41.3 | 41.3 | 39.81 | 60.20 |
| 9 | - | 165.8 | 170.82 | - |
| 10 | - | 152.9 | 69.84 | - |
| 11 | - | 28.7 | 31.57 | - |
| 12 | - | 113.1 | 137.66 | - |
| 13 | - | 134.7 | 133.21 | - |
| 14 | - | 130.3 | 117.58 | - |
| 15 | - | 155.8 | 152.34 | - |
| 16 | - | 112.1 | 117.58 | - |
| 17 | - | 131.7 | 133.21 | - |
| 1’ | 71.7 | 71.7 | 69.71 | 71.00 |
| 2’ | 26.4 | 26.4 | 25.38 | 26.79 |
| 3’ | 56.9 | 56.9 | 55.41 | 55.77 |
| MeO | - | 56.7 | 60.39 | - |
| +N(Me)2 | 43.7/43.6 | 43.7 | 41.51/42.92 | 44.06 |
| +N(Me)3 | - | - | - | 44.74 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Verongiaquinol.
| Position | 90 | 97 | 98 |
|---|---|---|---|
| 1 | 172.6 | 183.0 | 183.0 |
| 2 | 119.9 | 122.7 | 123.7 |
| 3 | 153.2 | 151.7 | 146.6 |
| 4 | 70.8 | 75.5 | 74.2 |
| 5 | 148.8 | 78.4 | 78.9 |
| 6 | 127.6 | 56.1 | 57.1 |
| 1′ | - | 116.9 | 116.9 |
| 2′ | - | 28.4 | 28.4 |
| CH2 | 45.1 | - | - |
| CONH2 | 169.4 | - | - |
Figure 1Metabolism of the bromotyrosine derived metabolites ( For the steps clarified in previous studies and For the biogenesis hypothesis).
Figure 2Spiroisoxazoline and acetal formation as production artefacts.
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Cavernicolins.
| Position | 5 | 6 | 9 | 11 | 12 | 13 | 14 |
|---|---|---|---|---|---|---|---|
| 1 | 184.0 | 184.0 | 183.4 | 188.91 | 188.89 | 80.90 | 82.7 |
| 2 | 56.9 | 53.1 | 58.0 | 39.78 | 40.08 | - | - |
| 3 | 68.7 | 64.7 | 67.9 | 58.60 | 58.56 | 168.30 | 171.4 |
| 4 | 76.6 | 75.7 | 74.4 | 74.15 | 73.41 | 43.1 | 44.0 |
| 5 | 149.9 | 149.0 | 146.3 | 150.07 | 145.84 | 69.5 | 69.5 |
| 6 | 120.8 | 120.8 | 127.4 | 122.45 | 130.18 | 156.90 | 153.2 |
| 7 | 43.0 | 45.1 | 42.4 | 43.58 | 43.78 | 118.80 | 129.5 |
| 8 | 173.9 | 173.9 | 173.6 | 172.65 | 172.72 | 187.8 | 188.9 |
| 9 | - | - | - | - | - | 46.6 | 47.6 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Hydroverongiaquinols.
| Position | 20 |
|---|---|
| 1 | 130.0 |
| 2 | 133.0 |
| 3 | 111.0 |
| 4 | 150.0 |
| 5 | 111.0 |
| 6 | 133.0 |
| 2’ | 40.0 |
| 3’ | 173.4 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Bromotyrosineketals.
| Position | 22 | 23 |
|---|---|---|
| 1 | 71.3 | 123.55 |
| 2 | 140.3 | 123.55 |
| 3 | 124.1 | 142.11 |
| 4 | 96.7 | 71.92 |
| 5 | 124.1 | 142.11 |
| 6 | 140.3 | 123.55 |
| 7 | 44.2 | 45.03 |
| 8 | 173.2 | 172.99 |
| 9 | 51.3 | 51.04 |
| 10 | 60.2 | 63.98 |
| 11 | 15.4 | 32.34 |
| 12 | - | 20.04 |
| 13 | - | 14.10 |
| 14 | - | - |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Bromotyrosine Lactone Derivatives.
| Position | 25 | 26 | 27 | 28 |
|---|---|---|---|---|
| 1 | 89.1 | 148.85 | 154.29 | 161.3 |
| 2 | 135.5 | 109.12 | 100.74 | 106.7 |
| 3 | 119.3 | 103.75 | 161.97 | 155.2 |
| 4 | 151.2 | 147.16 | 111.80 | 110.8 |
| 5 | 107.6 | 103.75 | 125.75 | 135.2 |
| 6 | 77.0 | 113.68 | 122.35 | 117.0 |
| 7 | 42.2 | 146.35 | 117.53 | 40.6 |
| 8 | 173.7 | 165.91 | 165.23 | 164.0 |
| 9 | - | 144.60 | - | - |
| 10 | - | 128.12 | 150.75 | - |
| 11 | - | 128.12 | 25.21 | - |
| 12 | - | 19.79 | 23.69 | - |
| MeO | 61.5 | - | 61.0 | 60.8 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Oxazolides.
| Position | 29 | 30 | 31 | 32 |
|---|---|---|---|---|
| 1 | 153.5 | 151.6 | 142.3 | 140.45 |
| 2 | 119.3 | 117.6 | 118.2 | 118.63 |
| 3 | 131.9 | 130.7 | 130.8 | 131.45 |
| 4 | 140.6 | 138.9 | 140.0 | 152.60 |
| 5 | 131.9 | 130.7 | 130.8 | 131.45 |
| 6 | 119.3 | 117.6 | 142.3 | 118.63 |
| 7 | 76.3 | 74.3 | 54.3 | 75.78 |
| 8 | 47.9 | 46.9 | 47.0 | 48.42 |
| 9 | 159.8 | 158.5 or 158.2 | 157.8 | 159.05 |
| 10 | 75.0 | 73.0 | 53.0 | 72.05 |
| 11 | 75.5 | 73.5 | 53.55 | |
| 12 | 41.7 | 41.1 | 41.47 | 46.97 |
| 13 | 160.2 | 161.35 | 158.4 | 161.35 |
| MeO | - | - | - | 50.25 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Spiroisoxazolines.
| Position | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 75.28 | 75.0 | 75.42 | 75.47 | 75.47 | 75.29 | 75.11 | 75.09 | 75.5 |
| 2 | 122.07 | 122.0 | 122.74 | 114.14 | 114.14 | 122.11 | 122.11 | 122.10 | 114.2 |
| 3 | 148.77 | 148.6 | 149.28 | 149.28 | 149.28 | 148.82 | 148.73 | 148.75 | 149.3 |
| 4 | 113.81 | 113.7 | 114.16 | 122.78 | 122.78 | 113.85 | 113.85 | 113.78 | 122.7 |
| 5 | 132.37 | 132.0 | 132.24 | 132.23 | 132.23 | 132.24 | 132.27 | 132.28 | 133.2 |
| 6 | 91.67 | 91.8 | 92.48 | 92.64 | 92.64 | 90.04 | 91.95 | 91.56 | 92.6 |
| 7 | 40.13 | 39.8 | 40.13 | 40.09 | 40.09 | 39.99 | 39.87 | 40.03 | 40.1 |
| 8 | 155.24 | 154.9 | 155.27 | 155.12 | 155.12 | 154.80 | 154.79 | 155.14 | 155.5 |
| 9 | 160.07 | 160.4 | 161.81 | 161.93 | 161.93 | 160.29 | 160.24 | 160.00 | 161.6 |
| 1′ | 75.28 | 75.1 | 75.42 | 75.47 | 75.47 | 75.29 | 75.18 | 75.20 | 75.5 |
| 2′ | 122.07 | 122.1 | 122.74 | 114.14 | 114.14 | 122.11 | 122.11 | 122.10 | 114.2 |
| 3′ | 148.77 | 148.6 | 149.28 | 149.28 | 149.28 | 148.82 | 148.74 | 148.75 | 149.3 |
| 4′ | 113.81 | 113.7 | 114.16 | 122.78 | 122.78 | 113.85 | 113.85 | 113.78 | 122.7 |
| 5′ | 132.30 | 132.1 | 132.16 | 133.21 | 133.21 | 132.23 | 132.28 | 132.28 | 133.2 |
| 6′ | 91.67 | 91.8 | 92.48 | 92.54 | 92.54 | 91.86 | 91.59 | 91.76 | 92.6 |
| 7′ | 40.09 | 39.9 | 40.04 | 40.03 | 40.03 | 39.89 | 40.09 | 40.08 | 40.1 |
| 8′ | 155.14 | 155.0 | 154.12 | 154.92 | 154.92 | 155.16 | 155.16 | 155.16 | 155.5 |
| 9′ | 160.01 | 160.5 | 161.55 | 161.80 | 161.80 | 160.48 | 160.03 | 160.41 | 161.6 |
| 10 | 37.47 | 43.4 | 37.94 | 49.87 | 49.87 | 47.52 | 47.46 | 43.49 | 38.4 |
| 11 | 30.55 | 69.7 | 30.59 | 207.84 | 207.84 | 200.82 | 200.87 | 69.68 | 26.1 |
| 12 | 72.16 | 75.7 | 71.61 | 75.73 | 75.73 | 76.52 | 76.48 | 75.79 | 26.1 |
| 13 | 152.30 | 152.5 | 153.56 | 43.43 | 43.43 | 151.93 | 151.23 | 151.97 | 38.4 |
| 14 | 118.48 | 118.3 | 118.99 | - | - | 118.11 | 118.07 | 118.31 | - |
| 15 | 134.06 | 131.3 | 131.69 | - | - | 131.55 | 134.21 | 134.14 | - |
| 16 | 139.63 | 142.9 | 143.06 | - | - | 143.93 | 140.53 | 139.88 | - |
| 17 | 134.06 | 131.3 | 131.69 | - | - | 131.55 | 134.21 | 134.14 | - |
| 18 | 118.48 | 118.3 | 118.99 | - | - | 118.11 | 118.07 | 118.31 | - |
| 19 | 34.75 | 71.3 | 72.18 | - | - | 71.46 | 34.74 | 34.71 | - |
| 20 | 40.96 | 47.5 | 47.63 | - | - | 47.60 | 40.85 | 40.91 | - |
| MeO | 60.21 | 60.2 | 60.35 | 60.39 | 60.39 | 60.23 | 60.19 | 60.19 | 60.4 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Verongiabenzenoids.
| Position | 82 | 83 |
|---|---|---|
| 1 | 154.87 | 152.19 |
| 2 | 111.18 | 117.30 |
| 3 | 134.63 | 133.35 |
| 4 | 129.20 | 135.92 |
| 5 | 130.33 | 133.35 |
| 6 | 117.68 | 117.30 |
| 7 | 29.07 | 26.88 |
| 8 | 68.51 | 65.07 |
| OMe | 59.88 | 60.31 |
| (Me)3N+ | 53.77 | 52.23 |
Compilation of the 13C NMR data of the halogenated substances from the genus Aplysina. Dibromocyclohexadiene.
| Position | 101 |
|---|---|
| 1 | 86.3 |
| 2 | 109.1 |
| 3 | 149.7 |
| 4 | 113.6 |
| 5 | 140.4 |
| 6 | 76.5 |
| 7 | 42.1 |
| 8 | 172.8 |
| 9 | 60.2 |
| 10 | 60.3 |